Bactericidal mode of action of bedaquiline
- PMID: 25754998
- DOI: 10.1093/jac/dkv054
Bactericidal mode of action of bedaquiline
Abstract
Objectives: It is not fully understood why inhibiting ATP synthesis in Mycobacterium species leads to death in non-replicating cells. We investigated the bactericidal mode of action of the anti-tubercular F1Fo-ATP synthase inhibitor bedaquiline (Sirturo™) in order to further understand the lethality of ATP synthase inhibition.
Methods: Mycobacterium smegmatis strains were used for all the experiments. Growth and survival during a bedaquiline challenge were performed in multiple media types. A time-course microarray was performed during initial bedaquiline challenge in minimal medium. Oxygen consumption and proton-motive force measurements were performed on whole cells and inverted membrane vesicles, respectively.
Results: A killing of 3 log10 cfu/mL was achieved 4-fold more quickly in minimal medium (a glycerol carbon source) versus rich medium (LB with Tween 80) during bedaquiline challenge. Assessing the accelerated killing condition, we identified a transcriptional remodelling of metabolism that was consistent with respiratory dysfunction but inconsistent with ATP depletion. In glycerol-energized cell suspensions, bedaquiline caused an immediate 2.3-fold increase in oxygen consumption. Bedaquiline collapsed the transmembrane pH gradient, but not the membrane potential, in a dose-dependent manner. Both these effects were dependent on binding to the F1Fo-ATP synthase.
Conclusions: Challenge with bedaquiline results in an electroneutral uncoupling of respiration-driven ATP synthesis. This may be a determinant of the bactericidal effects of bedaquiline, while ATP depletion may be a determinant of its delayed onset of killing. We propose that bedaquiline binds to and perturbs the a-c subunit interface of the Fo, leading to futile proton cycling, which is known to be lethal to mycobacteria.
Keywords: F1Fo-ATP synthase; R207910; TMC207; antimycobacterial agents; mycobacteria.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
TBAJ-876 Displays Bedaquiline-Like Mycobactericidal Potency without Retaining the Parental Drug's Uncoupler Activity.Antimicrob Agents Chemother. 2020 Jan 27;64(2):e01540-19. doi: 10.1128/AAC.01540-19. Print 2020 Jan 27. Antimicrob Agents Chemother. 2020. PMID: 31712198 Free PMC article.
-
Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.Pharmacotherapy. 2014 Nov;34(11):1187-97. doi: 10.1002/phar.1482. Epub 2014 Sep 9. Pharmacotherapy. 2014. PMID: 25203970 Review.
-
The ATP synthase inhibitor bedaquiline interferes with small-molecule efflux in Mycobacterium smegmatis.J Antibiot (Tokyo). 2014 Dec;67(12):835-7. doi: 10.1038/ja.2014.74. Epub 2014 Jun 11. J Antibiot (Tokyo). 2014. PMID: 24916895 No abstract available.
-
Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase.Antimicrob Agents Chemother. 2016 Oct 21;60(11):6977-6979. doi: 10.1128/AAC.01291-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27620476 Free PMC article.
-
TMC207 becomes bedaquiline, a new anti-TB drug.Future Microbiol. 2013 Sep;8(9):1071-80. doi: 10.2217/fmb.13.85. Future Microbiol. 2013. PMID: 24020736 Review.
Cited by
-
Cardiolipin enhances the enzymatic activity of cytochrome bd and cytochrome bo3 solubilized in dodecyl-maltoside.Sci Rep. 2021 Apr 13;11(1):8006. doi: 10.1038/s41598-021-87354-0. Sci Rep. 2021. PMID: 33850195 Free PMC article.
-
Aureolic Acid Group of Agents as Potential Antituberculosis Drugs.Antibiotics (Basel). 2020 Oct 19;9(10):715. doi: 10.3390/antibiotics9100715. Antibiotics (Basel). 2020. PMID: 33086595 Free PMC article.
-
Deciphering functional redundancy and energetics of malate oxidation in mycobacteria.J Biol Chem. 2022 May;298(5):101859. doi: 10.1016/j.jbc.2022.101859. Epub 2022 Mar 23. J Biol Chem. 2022. PMID: 35337802 Free PMC article.
-
Insight Into the Anti-staphylococcal Activity of JBC 1847 at Sub-Inhibitory Concentration.Front Microbiol. 2022 Jan 5;12:786173. doi: 10.3389/fmicb.2021.786173. eCollection 2021. Front Microbiol. 2022. PMID: 35069485 Free PMC article.
-
Alanine dehydrogenases in mycobacteria.J Microbiol. 2019 Feb;57(2):81-92. doi: 10.1007/s12275-019-8543-7. Epub 2019 Jan 31. J Microbiol. 2019. PMID: 30706339 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases